The Different Mechanisms of Cancer Drug Resistance: A Brief Review
- PMID: 29071215
- PMCID: PMC5651054
- DOI: 10.15171/apb.2017.041
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Abstract
Anticancer drugs resistance is a complex process that arises from altering in the drug targets. Advances in the DNA microarray, proteomics technology and the development of targeted therapies provide the new strategies to overcome the drug resistance. Although a design of the new chemotherapy agents is growing quickly, effective chemotherapy agent has not been discovered against the advanced stage of cancer (such as invasion and metastasis). The cancer cell resistance against the anticancer agents can be due to many factors such as the individual's genetic differences, especially in tumoral somatic cells. Also, the cancer drug resistance is acquired, the drug resistance can be occurred by different mechanisms, including multi-drug resistance, cell death inhibiting (apoptosis suppression), altering in the drug metabolism, epigenetic and drug targets, enhancing DNA repair and gene amplification. In this review, we outlined the mechanisms of cancer drug resistance and in following, the treatment failures by common chemotherapy agents in the different type of cancers.
Keywords: Cancer; Cell death inhibiting; Drug resistance; Epigenetic; Multi-drug resistance; microRNA.
Figures
Similar articles
-
Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.Curr Drug Metab. 2019;20(14):1114-1131. doi: 10.2174/1389200221666200103111539. Curr Drug Metab. 2019. PMID: 31902353 Review.
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification.Drug Resist Updat. 2020 Dec;53:100720. doi: 10.1016/j.drup.2020.100720. Epub 2020 Aug 20. Drug Resist Updat. 2020. PMID: 32892147 Review.
-
The challenge of drug resistance in cancer treatment: a current overview.Clin Exp Metastasis. 2018 Apr;35(4):309-318. doi: 10.1007/s10585-018-9903-0. Epub 2018 May 24. Clin Exp Metastasis. 2018. PMID: 29799080 Review.
Cited by
-
Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis.Front Oncol. 2022 Oct 13;12:911856. doi: 10.3389/fonc.2022.911856. eCollection 2022. Front Oncol. 2022. PMID: 36313731 Free PMC article. Review.
-
Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategies.Heliyon. 2024 Sep 5;10(17):e37488. doi: 10.1016/j.heliyon.2024.e37488. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39296198 Free PMC article.
-
SP-8356: A Novel Verbenone Derivative Exerts In Vitro Anti-Non-Small Cell Lung Cancer Effects, Promotes Apoptosis via The P53/MDM2 Axis and Inhibits Tumor Formation in Mice.Cell J. 2023 Dec 31;25(12):839-846. doi: 10.22074/cellj.2023.2008708.1385. Cell J. 2023. PMID: 38192254 Free PMC article.
-
Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.Front Immunol. 2022 Oct 5;13:996145. doi: 10.3389/fimmu.2022.996145. eCollection 2022. Front Immunol. 2022. PMID: 36275750 Free PMC article. Review.
-
Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway.J Oncol. 2021 Apr 21;2021:9992218. doi: 10.1155/2021/9992218. eCollection 2021. J Oncol. 2021. PMID: 33976698 Free PMC article.
References
-
- Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A, McLennan MT. Nitrogen mustard therapy: Use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. JAMA. 1946;132(3):126–32. doi: 10.1001/jama.1946.02870380008004. - DOI - PubMed
-
- Barinaga M. From bench top to bedside. Science. 1997;278(5340):1036–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources